title: Regression of sclerodermatous skin lesions in a patient with carcinoid syndrome treated by octreotide.
authors.forename: M
authors.initials: M
authors.lastname: Pavlovic
authors.forename: P
authors.initials: P
authors.lastname: Saiag
authors.forename: J P
authors.initials: JP
authors.lastname: Lotz
authors.forename: E
authors.initials: E
authors.lastname: Marinho
authors.forename: T
authors.initials: T
authors.lastname: Clerici
authors.forename: V
authors.initials: V
authors.lastname: Izrael
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008303:Malignant Carcinoid Syndrome / Q000150:complications* / Q000188:drug therapy; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D012075:Remission, Spontaneous; D012594:Scleroderma, Localized / Q000209:etiology*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide